SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-001721
Filing Date
2018-03-08
Accepted
2018-03-08 16:36:30
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K edit-20171231x10k.htm 10-K 4038028
2 EX-23.1 edit-20171231ex2316e67f0.htm EX-23.1 3409
3 EX-31.1 edit-20171231ex3112feff3.htm EX-31.1 17728
4 EX-31.2 edit-20171231ex3123fb92a.htm EX-31.2 17264
5 EX-32.1 edit-20171231ex3217aae9b.htm EX-32.1 15367
6 GRAPHIC edit20171231x10k001.jpg GRAPHIC 14881
7 GRAPHIC edit20171231x10k002.jpg GRAPHIC 64343
8 GRAPHIC edit20171231x10k003.jpg GRAPHIC 28892
  Complete submission text file 0001558370-18-001721.txt   11675547

Data Files

Seq Description Document Type Size
9 EX-101.INS edit-20171231.xml EX-101.INS 2117741
10 EX-101.SCH edit-20171231.xsd EX-101.SCH 77810
11 EX-101.CAL edit-20171231_cal.xml EX-101.CAL 67155
12 EX-101.DEF edit-20171231_def.xml EX-101.DEF 276031
13 EX-101.LAB edit-20171231_lab.xml EX-101.LAB 661638
14 EX-101.PRE edit-20171231_pre.xml EX-101.PRE 503670
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37687 | Film No.: 18676966
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences